Swedish Firms Pledpharma And RTT Merge To Target Orphan Drug Space

Two Late-Stage Assets For Rare Diseases

 
• By Kevin Grogan
  
Swedish flags
Two Swiss companies form new firm targeting orphan diseases • Source: Shutterstock

More from Rare Diseases

More from Scrip